Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
Letter to the Editor: Beyond the liver - integrating emerging predictors in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
Cristian Lindner, Department of Vascular and Interventional Radiology, Dr. Cesar Garavagno Burotto Talca Regional Hospital, Talca 3460000, Chile
Andrés Concha, Department of Radiology, Faculty of Medicine, University of Concepción, Concepción 4030000, Chile
Andrés Concha, David Clemo, Department of Radiology, Hospital Clínico Regional Dr. Guiller mo Grant Benavente, Concepción 4030000, Chile
Author contributions: Lindner C designed the overall concept and outline of the manuscript; Concha A and Clemo D contributed to drafting and revising the manuscript. All authors contributed to the original ideas and writing of this paper.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Cristian Lindner, MD, Department of Vascular and Interventional Radiology, Dr. Cesar Garavagno Burotto Talca Regional Hospital, Talca 3460000, Chile. clindner146@gmail.com
Received: February 2, 2026
Revised: February 20, 2026
Accepted: March 24, 2026
Published online: June 28, 2026
Processing time: 145 Days and 4.5 Hours
Revised: February 20, 2026
Accepted: March 24, 2026
Published online: June 28, 2026
Processing time: 145 Days and 4.5 Hours
Core Tip
Core Tip: While Zhuang et al identify cerebral hypoperfusion as a hallmark of post-transjugular intrahepatic portosystemic shunt encephalopathy, this letter argues that these changes represent the final downstream consequence of a systemic multi-hit failure. We integrate emerging evidence on the gut-liver-muscle axis, emphasizing that sarcopenia, the AMMON-OHE model, and shunt magnitude are critical upstream determinants of neurotoxicity. We propose that to prevent cognitive decline, specialists must move beyond isolated hemodynamic targets and adopt a precision medicine approach, tailoring stent expansion to the patient's individual metabolic and muscular reserve.